Down syndrome and COVID-19 [COVID-19]
Research type
Research Study
Full title
Down syndrome and COVID-19
IRAS ID
284388
Contact name
Andre Strydom
Contact email
Sponsor organisation
King's College London
Duration of Study in the UK
1 years, 3 months, 12 days
Research summary
People with Down syndrome (DS), caused by trisomy 21, have many co-occurring conditions beyond intellectual disability, that may increase their risk for COVID-19 or its progression. For example, their immune system compromises their ability to fight respiratory infections. This might also be true for viral infections, but there is no literature that addresses this question. Our survey study proposes to collect anonymous data from families and clinicians who are caring for people with DS affected with COVID-19 to identify specific risk factors based on co-occurring conditions and to determine whether disease progression is associated with these pre-existing conditions. This study will be done at an international level and is undertaken in association with the Trisomy 21 Research Society (T21RS).\n\nSee attached protocol for details
REC name
N/A
REC reference
N/A